Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in children

Natama HM., Salkeld J., Somé A., Soremekun S., Diallo S., Traoré O., Rouamba T., Ouédraogo F., Ouédraogo E., Daboné KCS., Koné NA., Compaoré ZMJ., Kafando M., Bonko MDA., Konaté F., Sorgho H., Nielsen CM., Pipini D., Diouf A., King LDW., Shaligram U., Long CA., Cho J-S., Lawrie AM., Skinner K., Roberts R., Miura K., Bradley J., Silk SE., Draper SJ., Tinto H., Minassian AM.

DOI

10.1101/2024.10.15.24315473

Type

Publication Date

16/10/2024

Permalink Original publication